Search | IOVS | ARVO Journals

View

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

High-Energy Collisional Dissociation Fragmentation of CEP and CML Peptides

Geeng-Fu Jang; Jack S Crabb; Lei Zhang; Joe G Hollyfield; Robert G Salomon; John W Crabb

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5258. doi:

ARVO Annual Meeting Abstract September 2016

Mass Spectrometric Detection of Carboxyethylpyrrole in Proteins

Geeng-Fu Jang; Lei Zhang; Jack Crabb; Hua Wang; Joe G Hollyfield; Robert G. Salomon; John W Crabb

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5791. doi:

ARVO Annual Meeting Abstract March 2012

Polarization Of Macrophages Toward M1 Pro-inflammatory Phenotype By Oxidative Stress-induced Modifications Associated With Age-related Macular Degeneration

Ali M. Saeed; Fernando Cruz-Guilloty; Stephanie J. Duffort; Robert G. Salomon; Victor L. Perez

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2716. doi:

ARVO Annual Meeting Abstract March 2012

Quantification Of CEP By LC MS/MS

Geeng-Fu Jang; Lei Zhang; Li Hong; Hua Wang; Robert G. Salomon; John W. Crabb

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6478. doi:

ARVO Annual Meeting Abstract March 2012

Carboxyethylpyrrole-specific T cells Promote M1 Macrophage Polarization: Innate and Adaptive Immunity Cooperate in the Early Onset of Age-Related Macular Degeneration

Fernando Cruz Guilloty; Ali Saeed; Stephanie Duffort; Yaohong Tan; Asha Ballmick; Robert G. Salomon; Victor L. Perez

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1237. doi:

ARVO Annual Meeting Abstract April 2011

Post-translational Modification Of CYP27A1 By Oxidative Derivatives Of Arachidonic Acid, Isolevuglandins, Occurs In Human Retina

Casey D. Charvet; Gun Young Heo; James Laird; Robert G. Salomon; Illarion V. Turko; Irina A. Pikuleva

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2348. doi:

ARVO Annual Meeting Abstract April 2010

AMD-Like Changes in Cfh Transgenic Mice: Can Antigen-Specific Immunity Enhance the Phenotype?

B. Aredo; A. McMahon; P. W. Chen; J. Y. Niederkorn; L. Hong; R. G. Salomon; W. Kedzierski; R. Ufret-Vincenty

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6131. doi:

ARVO Annual Meeting Abstract April 2010

Sustained RPE Pathology During Aging of Mice Immunized With CEP-MSA

J. G. Hollyfield; M. E. Rayborn; M. Yu; K. G. Shadrach; X. Yang; B. A. Bell; N. S. Peachey; R. G. Salomon

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6136. doi:

ARVO Annual Meeting Abstract April 2010

Autoreactive T Cells, but Not B Cells, Lead the Adaptive Immune Response Against Oxidative Stress-Mediated Modifications of Self Antigens in a Mouse Model of Age-Related Macular Degeneration

F. Cruz Guilloty; J. J. Echegaray; Y. Tan; E. J. Ewald; R. G. Salomon; V. L. Perez

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):408. doi:

ARVO Annual Meeting Abstract April 2009

Drugs That Prevent Retinal Light Damage Impact CEP Biomarker Levels

K. Renganathan; J. Gu; R. Collier; C. Romano; R. G. Salomon; M. Rayborn; J. G. Hollyfield; J. W. Crabb

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):681. doi:

ARVO Annual Meeting Abstract April 2009

Predicting Susceptibility to Age-Related Macular Degeneration With Genomic and Proteomic Biomarkers

S. A. Hagstrom; J. Gu; G. J. T. Pauer; X. Yue; U. Narendra; G. M. Sturgill; N. S. Peachey; R. G. Salomon; J. W. Crabb; Clinical Genomic and Proteomic AMD Study Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2342. doi:

ARVO Annual Meeting Abstract April 2009

Increased Isolevuglandin Modified Proteins in Glaucomatous Astrocytes

A. K. Junk; B. Govindarajan; M. Algeciras; R. G. Salomon; B. Anand-Apte; S. K. Bhattacharya

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3623. doi:

ARVO Annual Meeting Abstract April 2009

Antibody Mapping of Complement C3 Binding to CEP-BSA

L. A. Kuttner-Kondo; L. Hong; R. G. Salomon; J. G. Hollyfield

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4942. doi:

ARVO Annual Meeting Abstract May 2008

Correlation Between RPE Pathology and CEP Antibody Titer in Mice Immunized With CEP-MSA

J. G. Hollyfield; M. E. Rayborn; K. G. Shadrach; X. Yang; Y. Li; R. G. Salomon; V. Perez

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):474. doi:

ARVO Annual Meeting Abstract May 2008

Calpain-1 Processing Differences in Normal and Diseased Ocular Tissues

W.-H. Lee; A. Junk; B. Govindarajan; J. Laird; R. G. Salomon; S. K. Bhattacharya

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):675. doi:

ARVO Annual Meeting Abstract May 2008

Identification of Carboxyethylpyrrole-Modified Proteins in AMD Plasma

X. Zhan; J. Gu; X. Gu; J. S. Crabb; P. Nerone; S. Bamba; X. Yue; R. G. Salomon; J. W. Crabb; the Cleveland AMD Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1365. doi:

ARVO Annual Meeting Abstract May 2008

Role of Oxidatively Modified Extracellular Matrix Proteins and Matrix Metalloproteinases in Glaucomatous Trabecular Meshwork

B. Govindarajan; R. G. Salomon; S. K. Bhattacharya; B. Anand-Apte

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):1645. doi:

ARVO Annual Meeting Abstract May 2008

Electron Microscopic Analysis of Drusen Deposits That Develop Following Immunization With CEP-MSA

K. Sayanagi; Y. Li; M. E. Rayborn; K. G. Shadrach; X. Yang; V. Perez; R. G. Salomon; J. G. Hollyfield

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3967. doi:

ARVO Annual Meeting Abstract May 2008

Time Course for CEP Antibody Development and C3d Deposition in Bruch’s Membrane Following Immunization With CEP-MSA

T. Yamamoto; R. Venkatesh; X. Yang; Y. Li; M. E. Rayborn; K. G. Shadrach; V. Perez; R. G. Salomon; J. G. Hollyfield

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3969. doi:

ARVO Annual Meeting Abstract May 2008

Plasma Carboxyethylpyrrole and AMD Risk Genotypes

J. Gu; U. Narendra; G. Pauer; P. Nerone; S. Bamba; X. Yue; R. G. Salomon; S. A. Hagstrom; J. W. Crabb; Cleveland AMD Study Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):5161. doi:

1 2

Next 20 Results »

Advertisement